Development of an RNA Interference Therapeutic Targeting Angiopoietin-Like Protein 3 for Treatment of Hyperlipidemia

被引：0

作者：

Wong, So C. ^{[1
]}

Zhu, Rui ^{[1
]}

Hegge, Julia ^{[2
]}

Schienebeck, Casi ^{[2
]}

Christensen, Gary ^{[2
]}

Trilling, Lucas ^{[2
]}

Hamilton, Holly ^{[1
]}

Briggs, Jeremy ^{[1
]}

Hinkes, Meredith ^{[1
]}

Bertin, Stephanie ^{[1
]}

Andersen, Aaron ^{[1
]}

Seefeld, Mark ^{[3
]}

Li, Zhen ^{[2
]}

机构：

[1] Arrowhead Pharmaceut Inc, Biol, Madison, WI USA

[2] Arrowhead Pharmaceut Inc, Chem, Madison, WI USA

[3] Arrowhead Pharmaceut Inc, Toxicol, Madison, WI USA

来源：

CIRCULATION | 2018年 / 138卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A16636

引用

页数：2

共 50 条

[1] DEVELOPMENT OF A THERAPEUTIC VACCINE FOR DYSLIPIDEMIA AND RELATED DISEASES TARGETING ANGIOPOIETIN-LIKE PROTEIN 3 (ANGPTL3).
Fukami, Hirotaka
Morinaga, Jun
Nakagami, Hironori
Kuwabara, Takashige
Morishita, Ryuichi
Oike, Yuichi
Mukoyama, Masashi
[J]. JOURNAL OF HYPERTENSION, 2023, 41 : E270 - E271
[2] Angiopoietin-like protein 3 markedly enhanced in the hyperlipidemia related proteinuria
Xia Gao
Yanhong Suo
Min Zhang
Yan Wang
Xin Gao
Qiu Bing
Qingju Liu
[J]. Lipids in Health and Disease, 18
[3] Angiopoietin-like protein 3 markedly enhanced in the hyperlipidemia related proteinuria
Gao, Xia
Suo, Yanhong
Zhang, Min
Wang, Yan
Gao, Xin
Bing, Qiu
Liu, Qingju
[J]. LIPIDS IN HEALTH AND DISEASE, 2019, 18 (1)
[4] Reduction in Angiopoietin-Like Protein 3 via RNA Interference Improves Dyslipidemias and Hepatic Steatosis
Wong, So C.
Zhu, Rui
Havel, Peter J.
Hamilton, James
Graham, James
Hegge, Julia
Schienebeck, Casi
Christensen, Gary
Trilling, Lucas
Hamilton, Holly
Briggs, Jeremy
Hinkes, Meredith
Bertin, Stephanie
Seefeld, Mark
Given, Bruce
Li, Zhen
[J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39
[5] Pharmacodynamic Effect of ARO-ANG3, an Investigational RNA Interference Targeting Hepatic Angiopoietin-like Protein 3, in Patients With Hypercholesterolemia
Watts, Gerald F.
Schwabe, Christian
Scott, Russell
Gladding, Patrick
Sullivan, David
Baker, John
Clifton, Peter
Hamilton, James
Given, Bruce
Martin, Javier San
Melquist, Stacey
Chang, Ting
Rajicic, Natasa
Goldberg, Ira J.
Gaudet, Daniel
Knowles, Joshua W.
Hegele, Robert A.
Ballantyne, Christie M.
[J]. CIRCULATION, 2020, 142
[6] RNA Interference Targeting Liver Angiopoietin-Like Protein 3 Protects from Nephrotic Syndrome in a Rat Model Via Amelioration of Pathologic Hypertriglyceridemia
Zhao, Yitong
Goto, Masaki
Vaziri, Nosratola D.
Khazaeli, Mahyar
Liu, Han
Farahanchi, Nazli
Khanifar, Elham
Farzaneh, Ted
Haslett, Patrick A.
Moradi, Hamid
Soundarapandian, Mangala M.
[J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2021, 376 (03): : 428 - 435
[7] RNA Interference Targeting Hepatic Angiopoietin-Like Protein 3 Results in Prolonged Reductions in Plasma Triglycerides and LDL-C in Human Subjects
Watts, Gerald F.
Schwabe, Christian
Scott, Russell
Gladding, Patrick
Sullivan, David R.
Baker, John
Clifton, Peter
Hamilton, James
Given, Bruce
Melquist, Stacey
Knowles, Josh
Hegele, Robert A.
Ballantyne, Christie M.
[J]. CIRCULATION, 2019, 140 (25) : E987 - E988
[8] Lipid metabolism and the targeting of angiopoietin-like 3: Experimental drugs under development
Polychronopoulos, Georgios
Kostourou, Danai-Thomais
Tziomalos, Konstantinos
[J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (03) : 177 - 180
[9] Targeting angiopoietin-like 3 in atherosclerosis: From bench to bedside
Ling, Ping
Zheng, Xueying
Luo, Sihui
Ge, Junbo
Xu, Suowen
Weng, Jianping
[J]. DIABETES OBESITY & METABOLISM, 2021, 23 (09): : 2020 - 2034
[10] Regulation of the angiopoietin-like protein 3 gene by LXR
Kaplan, R
Zhang, T
Hernandez, M
Gan, FXD
Wright, SD
Waters, MG
Cai, TQ
[J]. JOURNAL OF LIPID RESEARCH, 2003, 44 (01) : 136 - 143

← 1 2 3 4 5 →